Estimation of Insulin Resistance in Mexican Adults by the [13C]Glucose Breath Test Corrected for Endogenous Total CO2 Production
Table 1
Clinical and metabolic characteristics of study subjects.
Variable
Diabetic
Normal weight
Overweight
Obese
Sex (F/M)
3/5
17/2
9/7
10/5
Age (years)
44.0 11.4
29.5 9.71
33.1 12.2
41.2 13.7
Weight (kg)
102 34.7
59 9.71
77.4 10.4
92.1 16.1
Height (cm)
165 10.9
164 6.03
168 10.3
164 9.94
Waist (cm)
115 23.8
79.9 6.68
92.4 5.58
106 9.94
Fat mass BIA (%)
44.2 5.75
28.6 11.2
35.6 8.81
45.1 7.68
Fasting insulin (μU/mL)
22.1 14.6
7.36 3.85
11.0 5.64
15.5 8.51
Fasting glucose (mg/dL)
140 56.6
87.8 12.9
94.9 11.1
102 30.3
Triglycerides (mg/dL)
167 69.4
101 45.0
147 86.3
192 110
HDL (mg/dL)
43.5 13.0
64.7 16.5
55.9 13.7
50.7 13.1
LDL (mg/dL)
138 36.8
77.3 54.9
130 55.8
135 70.6
SBP (mmHg)
127 17.9
109 9.54
121 19.8
139 18.5
DBP (mmHg)
83.3 6.18
72.2 7.97
79.0 10.5
87.7 7.70
13CO2 (‰)
7.36 4.65
14.1 6.21
12.0 3.96
8.20 3.33
Data are presented as mean SD. Abbreviations: F, female; M, male; BIA, electrical bioimpedance; c-HDL, high-density lipoprotein cholesterol; c-LDL, low-density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure; 13CO2 (‰), increase of 13CO2 from the basal level to that at the 90-minute time point.
